Healthcare & Life Sciences

CollageBio

About

CollageBio develops gene-based therapeutics using an AI-enhanced polynucleotide engineering platform to create stable, specific, and programmable medicines that combine gene editing durability with safe and reversible disease modulation.

Explore CollageBio's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.